Literature DB >> 8643457

Peroxo-iron and oxenoid-iron species as alternative oxygenating agents in cytochrome P450-catalyzed reactions: switching by threonine-302 to alanine mutagenesis of cytochrome P450 2B4.

A D Vaz1, S J Pernecky, G M Raner, M J Coon.   

Abstract

Among biological catalysts, cytochrome P450 is unmatched in its multiplicity of isoforms, inducers, substrates, and types of chemical reactions catalyzed. In the present study, evidence is given that this versatility extends to the nature of the active oxidant. Although mechanistic evidence from several laboratories points to a hypervalent iron-oxenoid species in P450-catalyzed oxygenation reactions, Akhtar and colleagues [Akhtar, M., Calder, M. R., Corina, D. L. & Wright, J. N. (1982) Biochem. J. 201, 569-580] proposed that in steroid deformylation effected by P450 aromatase an iron-peroxo species is involved. We have shown more recently that purified liver microsomal P450 cytochromes, including phenobarbital-induced P450 2B4, catalyze the analogous deformylation of a series of xenobiotic aldehydes with olefin formation. The investigation presented here on the effect of site-directed mutagenesis of threonine-302 to alanine on the activities of recombinant P450 2B4 with N-terminal amino acids 2-27 deleted [2B4 (delta2-27)] makes use of evidence from other laboratories that the corresponding mutation in bacterial P450s interferes with the activation of dioxygen to the oxenoid species by blocking proton delivery to the active site. The rates of NADPH oxidation, hydrogen peroxide production, and product formation from four substrates, including formaldehyde from benzphetamine N-demethylation, acetophenone from 1-phenylethanol oxidation, cyclohexanol from cyclohexane hydroxylation, and cyclohexene from cyclohexane carboxaldehyde deformylation, were determined with P450s 2B4, 2B4 (delta2-27), and 2B4 (delta2-27) T302A. Replacement of the threonine residue in the truncated cytochrome gave a 1.6- to 2.5-fold increase in peroxide formation in the presence of a substrate, but resulted in decreased product formation from benzphetamine (9-fold), cyclohexane (4-fold), and 1-phenylethanol (2-fold). In sharp contrast, the deformylation of cyclohexane carboxaldehyde by the T302A mutant was increased about 10-fold. On the basis of these findings and our previous evidence that aldehyde deformylation is supported by added H202, but not by artificial oxidants, we conclude that the iron-peroxy species is the direct oxygen donor. It remains to be established which of the many other oxidative reactions involving P450 utilize this species and the extent to which peroxo-iron and oxenoid-iron function as alternative oxygenating agents with the numerous isoforms of this versatile catalyst.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8643457      PMCID: PMC39332          DOI: 10.1073/pnas.93.10.4644

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Properties of NADPH-cytochrome P-450 reductase purified from rabbit liver microsomes.

Authors:  J S French; M J Coon
Journal:  Arch Biochem Biophys       Date:  1979-07       Impact factor: 4.013

2.  Kinetics of reduction of cytochrome P-450LM4 in a reconstituted liver microsomal enzyme system.

Authors:  D D Oprian; K P Vatsis; M J Coon
Journal:  J Biol Chem       Date:  1979-09-25       Impact factor: 5.157

3.  Biological strategies for the manipulation of dioxygen. The chemistry of cytochrome P-450.

Authors:  J T Groves
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

4.  Solvent effects on reversible formation and oxidative stability of heme-oxygen complexes.

Authors:  W S Brinigar; C K Chang; J Geibel; T G Traylor
Journal:  J Am Chem Soc       Date:  1974-08-21       Impact factor: 15.419

5.  Interactions of cytochrome P-450, NADPH-cytochrome P-450 reductase, phospholipid, and substrate in the reconstituted liver microsomal enzyme system.

Authors:  J S French; F P Guengerich; M J Coon
Journal:  J Biol Chem       Date:  1980-05-10       Impact factor: 5.157

6.  Two forms of liver microsomal cytochrome P-450, P-450lm2 and P-450LM4 (rabbit liver).

Authors:  M J Coon; T A van der Hoeven; S B Dahl; D A Haugen
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

7.  Hydrogen peroxide in hepatic microsomes.

Authors:  A G Hildebrandt; I Roots; M Tjoe; G Heinemeyer
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

Review 8.  Oxygen activation by cytochrome P-450.

Authors:  R E White; M J Coon
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

9.  Mechanistic studies on C-19 demethylation in oestrogen biosynthesis.

Authors:  M Akhtar; M R Calder; D L Corina; J N Wright
Journal:  Biochem J       Date:  1982-03-01       Impact factor: 3.857

10.  The role of Thr268 in oxygen activation of cytochrome P450BM-3.

Authors:  H Yeom; S G Sligar; H Li; T L Poulos; A J Fulco
Journal:  Biochemistry       Date:  1995-11-14       Impact factor: 3.162

View more
  36 in total

1.  Structural analysis of mammalian cytochrome P450 2B4 covalently bound to the mechanism-based inactivator tert-butylphenylacetylene: insight into partial enzymatic activity.

Authors:  Sean C Gay; Haoming Zhang; P Ross Wilderman; Arthur G Roberts; Tong Liu; Sheng Li; Hsia-Lien Lin; Qinghai Zhang; Virgil L Woods; C David Stout; Paul F Hollenberg; James R Halpert
Journal:  Biochemistry       Date:  2011-05-13       Impact factor: 3.162

Review 2.  Hydroperoxoferric heme intermediate as a second electrophilic oxidant in cytochrome P450-catalyzed reactions.

Authors:  Shengxi Jin; Thomas A Bryson; John H Dawson
Journal:  J Biol Inorg Chem       Date:  2004-07-29       Impact factor: 3.358

3.  Oxoiron(IV) porphyrin pi-cation radical complexes with a chameleon behavior in cytochrome P450 model reactions.

Authors:  Woon Ju Song; Yon Ok Ryu; Rita Song; Wonwoo Nam
Journal:  J Biol Inorg Chem       Date:  2005-04-13       Impact factor: 3.358

4.  Proximal ligand electron donation and reactivity of the cytochrome P450 ferric-peroxo anion.

Authors:  Santhosh Sivaramakrishnan; Hugues Ouellet; Hirotoshi Matsumura; Shenheng Guan; Pierre Moënne-Loccoz; Alma L Burlingame; Paul R Ortiz de Montellano
Journal:  J Am Chem Soc       Date:  2012-04-04       Impact factor: 15.419

5.  A requirement for an active proton delivery network supports a compound I-mediated C-C bond cleavage in CYP51 catalysis.

Authors:  Tatiana Y Hargrove; Zdzislaw Wawrzak; F Peter Guengerich; Galina I Lepesheva
Journal:  J Biol Chem       Date:  2020-06-03       Impact factor: 5.157

6.  Structures of human cytochrome P-450 2E1. Insights into the binding of inhibitors and both small molecular weight and fatty acid substrates.

Authors:  Patrick R Porubsky; Kathleen M Meneely; Emily E Scott
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

7.  Active site proton delivery and the lyase activity of human CYP17A1.

Authors:  Yogan Khatri; Michael C Gregory; Yelena V Grinkova; Ilia G Denisov; Stephen G Sligar
Journal:  Biochem Biophys Res Commun       Date:  2013-12-02       Impact factor: 3.575

8.  Kinetic solvent isotope effect in steady-state turnover by CYP19A1 suggests involvement of Compound 1 for both hydroxylation and aromatization steps.

Authors:  Yogan Khatri; Abhinav Luthra; Ruchia Duggal; Stephen G Sligar
Journal:  FEBS Lett       Date:  2014-07-02       Impact factor: 4.124

9.  An open conformation of mammalian cytochrome P450 2B4 at 1.6-A resolution.

Authors:  Emily E Scott; You Ai He; Michael R Wester; Mark A White; Christopher C Chin; James R Halpert; Eric F Johnson; C David Stout
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-16       Impact factor: 11.205

10.  Desaturase reactions complicate the use of norcarane as a mechanistic probe. Unraveling the mixture of twenty-plus products formed in enzyme-catalyzed oxidations of norcarane.

Authors:  Martin Newcomb; R Esala P Chandrasena; Dharmika S P Lansakara-P; Hye-Yeong Kim; Stephen J Lippard; Laurance G Beauvais; Leslie J Murray; Viviana Izzo; Paul F Hollenberg; Minor J Coon
Journal:  J Org Chem       Date:  2007-02-16       Impact factor: 4.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.